NIST-sponsored National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) is dedicated to accelerating innovation in biopharmaceutical manufacturing of lifesaving therapeutics, solving industry challenges to enable cost-effective and rapid manufacturing, and creating a well-trained workforce for the field’s high-paying jobs.
NIIMBL was created in 2017 and is headquartered in Newark, Delaware.
Secretary Raimondo Announces $153 Million to Promote Innovation in Biopharmaceutical Manufacturing - 83 million in funding comes from the American Rescue Plan to support research and development to prevent, prepare for and respond to coronavirus outbreaks.